We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for belzutifan (Merck Sharp & Dohme (Australia) Pty Ltd)
Active ingredients
belzutifan
Date of review outcome
Lapse date
Type
Provisional determination
Dosage form(s)
Immediate-release tablet
Therapeutic area
Oncology